APA

Corbett M. A., Bellows S. T., Li M., Carroll R., Micallef S., Carvill G. L., Myers C. T., Howell K. B., Maljevic S., Lerche H., Gazina E. V., Mefford H. C., Bahlo M., Berkovic S. F., Petrou S., Scheffer I. E. & Gecz J. (20170515). Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. : Neurology.

Chicago

Corbett Mark A, Bellows Susannah T, Li Melody, Carroll Renée, Micallef Silvana, Carvill Gemma L, Myers Candace T, Howell Katherine B, Maljevic Snezana, Lerche Holger, Gazina Elena V, Mefford Heather C, Bahlo Melanie, Berkovic Samuel F, Petrou Steven, Scheffer Ingrid E and Gecz Jozef. 20170515. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. : Neurology.

Harvard

Corbett M. A., Bellows S. T., Li M., Carroll R., Micallef S., Carvill G. L., Myers C. T., Howell K. B., Maljevic S., Lerche H., Gazina E. V., Mefford H. C., Bahlo M., Berkovic S. F., Petrou S., Scheffer I. E. and Gecz J. (20170515). Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. : Neurology.

MLA

Corbett Mark A, Bellows Susannah T, Li Melody, Carroll Renée, Micallef Silvana, Carvill Gemma L, Myers Candace T, Howell Katherine B, Maljevic Snezana, Lerche Holger, Gazina Elena V, Mefford Heather C, Bahlo Melanie, Berkovic Samuel F, Petrou Steven, Scheffer Ingrid E and Gecz Jozef. Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. : Neurology. 20170515.